It’s all about consolidation these days – in pharma, medtech and biotech M&A
This year’s been a big deal for big deals in pharma, biotech and medtech: There have been 869 deals worth $354.3 billion, according to a new Mergermarket report – the most the firm’s seen since 2001 by value. This is attributed, of course, to the eight megadeals this year – representative of the mass consolidation […]